Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy–Innovative Models Prolong Survival (OCTIPS) Consortium

Ilary Ruscito, Dan Cacsire Castillo-tong, Ignace Vergote, Iulia Ignat, Mandy Stanske, Adriaan Vanderstichele, Ram N. Ganapathi, Jacek Glajzer, Hagen Kulbe, Fabian Trillsch, Alexander Mustea, Caroline Kreuzinger, Pierluigi Benedetti Panici, Charlie Gourley, Hani Gabra, Mirjana Kessler, Jalid Sehouli, Silvia Darb-esfahani, Elena Ioana Braicu

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)214-225
JournalEuropean Journal of Cancer
Volume79
DOIs
Publication statusPublished - 17 May 2017

Cite this